SCHEMBL5465684

SCHEMBL5465684

CC(C)(C)OC(=O)N1CC=C(c2ccc(NC(=O)Nc3ccccc3F)cc2)CC1

nearest known ligand 0.65

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NAMPT P43490 3/20 0.65
GRM5 P41594 8/20 0.52
GRM1 Q13255 8/20 0.52
PDK4 Q16654 1/20 0.48
NPC1 O15118 6/20 0.48
RAB9A P51151 6/20 0.48
SMN1; SMN2 Q16637 5/20 0.48
MAPT P10636 3/20 0.48
ALDH1A1 P00352 2/20 0.48
ALOX15 P16050 2/20 0.48
HPGD P15428 1/20 0.48
CASP3 P42574 1/20 0.48
SENP8 Q96LD8 1/20 0.48
SENP7 Q9BQF6 1/20 0.48
SENP6 Q9GZR1 1/20 0.48
NFKB1 P19838 2/20 0.47
NFKB2 Q00653 2/20 0.47
RELA Q04206 2/20 0.47
PKM P14618 1/20 0.47
HTT P42858 3/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5458325 0.87 NAMPT (0.64) NAMPTGRM5GRM1PDK4NPC1
SCHEMBL5463378 0.84 NPC1 (0.58) NAMPTNPC1RAB9ASMN1; SMN2MAPT
SCHEMBL22325022 0.81 NAMPT (0.71) NAMPTGRM5GRM1PDK4NPC1
SCHEMBL5453589 0.80 NAMPT (0.57) NAMPTGRM5GRM1RAB9ASMN1; SMN2
SCHEMBL5473484 0.80 NAMPT (0.62) NAMPTGRM5GRM1PDK4ALDH1A1
SCHEMBL5457840 0.80 NAMPT (0.62) NAMPTNPC1RAB9ASMN1; SMN2MAPT
SCHEMBL31488872 0.79 NAMPT (0.75) NAMPTNPC1RAB9ASMN1; SMN2MAPT
SCHEMBL12479794 0.79 NAMPT (0.55) NAMPTGRM5GRM1PDK4CDK7
SCHEMBL3707364 0.79 NAMPT (1.00) NAMPT
SCHEMBL31488923 0.79 NAMPT (0.68) NAMPTGRM5GRM1PDK4NPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20070249620-A1 Urea Derivative SANKYO COMPANY, LIMITED (JP) 2007-10-25 US disclosed
EP-1764360-A1 UREA DERIVATIVE Sankyo Company, Limited (JP) 2007-03-21 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070249620-A1 Urea Derivative UGP2, SLC14A1, DGAT1 NAMPT 324/4885GRM5 2380/4885GRM1 1612/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.